Business Wire

Belgravia Hartford Announces USD$5M Convertible Secured Debenture with Round13 DAF & Closing of C$4M Private Placement

16.7.2025 14:57:00 CEST | Business Wire | Press Release

Share

BELGRAVIA HARTFORD CAPITAL INC. (CSE:BLGV)(OTC:BLGVF)(FRA:ECA) ("Company" or “Belgravia”) is pleased to announce that:

  • it has entered into a binding agreement with Round13 Digital Asset Fund (“Round13 DAF”) for a secured convertible debenture for a one-time principal amount investment of USD$5,000,000 (the “Debenture”) convertible into common shares at C$0.71, being a 40% premium to the volume-weighted average trading price (the “VWAP”) for the seven consecutive days immediately preceding the date of this announcement; and
  • as a result of this above-market Debenture, Belgravia has elected to voluntarily reduce its non-brokered private placement to close on 16,091,822units (the “Units”) at a price of C$0.25 per Unit for aggregate gross proceeds of C$4,022,955.55(the “Offering”) to the Company.

New USD$5 Million Round13 DAF Debenture Convertible at C$0.71

The principal amount and interest of the Debenture is convertible into common shares of Belgravia at a conversion price (the “Conversion Price”) of C$0.71, being a 40% premium to the VWAP for the seven consecutive days immediately preceding the date of this announcement. In the case that, at any time prior to the maturity date of the Debenture, the VWAP of Belgravia common shares equals or exceeds C$1.42, being 200% of the Conversion Price for 20-consecutive trading days of the common shares on the Canadian Securities Exchange (the “CSE”), then 20% of the then-outstanding principal amount (together with a proportionate amount of accrued and unpaid interest) shall automatically convert into common shares of Belgravia without any further action of Round13 DAF. The Debenture bears interest at a rate of 4% per annum, accrued monthly, and matures two years from the closing date thereof.

Mehdi Azodi, CEO of Belgravia stated: “This continued support from Round13 DAF, our lead strategic advisor and partner in all areas of Bitcoin-related finance, results in any new securities issued being set at a 40% premium to the price of Belgravia shares for the seven consecutive days immediately preceding the date of the announcement – a far less dilutive mechanism for Belgravia to achieve its stated goals. In addition, as a result of this Debenture, Belgravia has determined that it is in the best interests of our shareholders, to voluntarily cap the Offering at slightly more than 40% of its initial size”.

Mehdi Azodi continued: “This path enables Belgravia to achieve an excess amount of additional Bitcoin than originally expected to our treasury but, most importantly, with almost 60% less dilution.”

Khaled Verjee, Managing Director of Round13 DAF added: “We are extremely pleased to continue to support our partners and believe Belgravia is building an innovative business where Bitcoin treasury strategies play an integral role. From its innovative capital structures, protecting shareholder value, to its suite of, soon to be launched, Bitcoin focused technical tools designed to increase shareholder value and growth at a BTC level, Belgravia is well-positioned in this space. For a microcap to be thinking the way Belgravia is, and to have the technical team it does, it is in our opinion a recipe for long term success”.

Closing of Offering

As disclosed by press release on June 24, 2025, the Company announced a non-brokered private placement of Units. Under the Offering, each Unit consists of one common share of the Company (a “CommonShare”) and one-half of one Common Share purchase warrant (each whole warrant, a “Warrant”) at a price of C$0.25 per Unit. Each Warrant entitles the holder to acquire one additional Common Share at an exercise price of C$0.50 per share for a period of 12-months from the date of issuance. The Warrants will be subject to an acceleration clause whereby, if the closing price of the Common Shares on the CSE is greater than C$0.75 for a period of ten consecutive trading days, the Company may accelerate the expiry date of the Warrants by giving notice to the holders thereof. In such case, the Warrants will expire 30-days after the date of such notice. Under the Offering, a total of 16,091,822Units were issued at a price of C$0.25 per Unit for aggregate gross proceeds of C$4,022,955.55.

No finders fees or commissions were paid to any party in connection with either the Offering or the Debenture.

In accordance with the policies of the CSE and applicable securities legislation,the Common Shares and Warrants comprising the Units will be subject to a hold period of four months and one day from the date of issuance. In addition, closing of the Debenture is subject to all rules, policies and procedures of the CSE.

Belgravia intends to use the proceeds of the Debenture and the Offering to purchase Bitcoin, in line with the Company’s strategic objective of building a 100% Bitcoin only Treasury.

For more information, legal disclaimer and about Belgravia Hartford please visit, please visit www.belgraviahartford.com or www.blgvbtc.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250715265083/en/

Contacts

For More Information, Please Contact:

Mehdi Azodi, President & CEO
Belgravia Hartford Capital Inc.
(416) 779-3268
mazodi@blgv.ca

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 18:09:00 CEST | Press Release

Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,

Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press Release

As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release

Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye